Triveni Bio raises $65M ahead of upcoming readouts on eczema drugs

Vishal Patel, Triveni Bio CEO June 17, 2026 07:00 AM EDT FinancingR&D Triveni Bio rais­es $65M ahead of up­com­ing read­outs on eczema drugs Lei Lei Wu News Reporter Triveni Bio an­nounced a $65 mil­lion Se­ries C af­ter its sec­ond as­set for eczema en­tered clin­i­cal stud­ies last month. The Se­ries C was co-led by … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER